期刊文献+

脑胶质瘤患者生存期的相关因素分析 被引量:3

Factors related to survival in glioma patients
原文传递
导出
摘要 目的探讨脑胶质瘤患者生存期的相关因素。方法对资料完整的109例脑胶质瘤患者进行观察和分析,对可能影响脑胶质瘤生存期的因素采用Kaplan—Meier法和Cox回归分析进行统计学验证。结果Kaplan-Meier法单因素分析显示年龄、部位、术前患者身体机能状况评分(KPS)、病理级别、瘤周水肿、肿瘤囊变、手术方式、术后放疗八个因素对患者生存时间产生显著影响:Cox回归多因素分析显示年龄、部位、术前KPS、病理级别、手术方式、术后放疗六个因素是决定患者生存时间的主要预后因素。结论结合预后影响因素,注意治疗中的各环节,合理安排治疗模式.将有助于改善脑胶质瘤患者的预后。 Objective To evaluate the factors related to survival in brain glioma patients. Methods 109 evaluable brain glioma patients were observed and analyzed. Kaplan-Meier and Cox regression model were used to evaluate the possible prognostic factors related to long-term survival in brain glioma patients. Results In analysis of Kaplan-Meier, the following factors had a significant influence on the survival time: age, position of tumor, kamofsky performance scale (KPS) scores before operation, pathological grade, peripheral edema, cystic changes of tumor, type of surgery, and postoperative radiotherapy. In multivariate analysis of Cox regression model, the following factors had a significant influence on the survival time: age, position of tumor, KPS scores before operation, pathological grade, type of surgery, and postoperative radiotherapy. Conclusion Paying attention to the details during treatment and making suitable therapeutic strategies based on the above factors will be able to elevate the long-term survival rate of brain glioma patients.
出处 《中华神经医学杂志》 CAS CSCD 2008年第2期157-159,共3页 Chinese Journal of Neuromedicine
关键词 神经胶质瘤 无病生存 相关因素 Glioma Disease-free surrival Correlation factor
  • 相关文献

参考文献8

二级参考文献37

  • 1楚胜华,袁先厚,陈卫国,江普查,郭国炳,吴涛,李志强,曹长军,陈新军,赵时雨,俞苏寰.幕上星形细胞瘤生存分析[J].第四军医大学学报,2004,25(17):1598-1602. 被引量:1
  • 2[1]Kondziolka D, Glickinger JC, Bissonette DJ, et al. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms [J]. Neurosurg, 1997, 41:776- 785.
  • 3[2]Shrieve DC, Alexander E, Black PM, et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: Prognostic factors and long-term outcome [J]. J Neurosurg, 1999, 90:72- 77.
  • 4[3]Gannett D, Stea B, Lulu B, et al. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant Gliomas [J]. Int J Radiat Oncol Biol Phys, 1995, 33:461- 468.
  • 5[4]Larson DA, Gutin PH, McDermott M, et al. Gamma Knife for gliomas:Selection factors and survival [J]. Int J Radiat Oncol Biol Phys, 1996,36:1045- 1053.
  • 6[5]Hodgson DC, Goumnerova LC, Loeffler JS, et al. Radiosurgery in the management of pediatric brain tumors [J]. Int J Radiat Oncol Biol phys, 2001, 50:929- 935.
  • 7[6]McDermott MW, Sneed PK, Chang SM, et al. Results of radiosurgery for recurrent gliomas [M]. In:Kondziolka D eds. Radiosurgery. 1st ed. Basel, Karger, 1996, 102- 112.
  • 8[7]Buatti JM, Friedman WA, Bova FJ, Mendenhall WM. Linac radiosurgery for high-grade gliomas:the University of Florida experience [J]. Int J Radiat Oncol Biol phys, 2001, 50:929- 935.
  • 9[8]Shepherd SF, Laing RW, Cosgrove VP, et al. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma [J]. Int J Radiat Oncol Biol Phys, 1997, 37:393- 398.
  • 10[9]Tarbell NJ, Loeffler JS. Recent trends in the radiotherapy of pediatric Gliomas [J]. J Neurooncol, 1996, 28:233- 244.

共引文献19

同被引文献21

  • 1Ying-Yan Yu , Zheng-Gang Zhu.Significance of biological resource collection and tumor tissue bank creation[J].World Journal of Gastrointestinal Oncology,2010,2(1):5-8. 被引量:10
  • 2康春生,浦佩玉,贾志凡,张志勇,王广秀,刘晓智,裘明哲.反义AKT2 RNA抑制U251胶质瘤细胞生长的体内外研究[J].中华神经医学杂志,2007,6(2):113-117. 被引量:7
  • 3Gallagher E, Mc Goldrick A, Chung WY, et al. Gain of imprinting of SLC22A18 sense and antisense transcripts in human breast cancer[J]. Genomics, 2006, 88(1): 12-17.
  • 4Li Y, Meng G, Guo QN. Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma[J]. Exp Mol Pathol, 2008, 84(3): 234-239.
  • 5Bajaj V, Singhmar P, Kumar A. Promoter characterization and regulation of expression of an imprinted gene SLC22AI8AS [J]. Gene, 2008, 424(1-2): 40-47.
  • 6Yi JM, Tsai HC, Glockner SC, et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors[J]. Cancer Res, 2008, 68(19): 8094-8103.
  • 7Rimel B J, Huettner P, Powell MA, et al. Absence of MGMT promoter methylation in endometrial cancer [J]. Gynecol Oncol, 2009, 112(1): 224-228.
  • 8Gonzalez E,McGraw TE.The Akt kinases:isoform specificity in metabolism and cancer.Cell Cvcle,2009,8:2502-2508.
  • 9Mure H,Matsuzaki K,Kitazato KT,et al.Akt2 and Akt3 play a pivotal role in malignant gliomas.Neuro-Oncology,2009,12:221-232.
  • 10Koul D,Shen R,Bergh S,et al.Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma.Mol Cancer Ther,2006,5:637-644.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部